Kugler A R, Olson S C, Smith D E
Department of Pharmacokinetics and Drug Metabolism, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, Michigan 48106-1047, USA.
J Pharmacokinet Biopharm. 1996 Aug;24(4):349-68. doi: 10.1007/BF02353517.
The clearance mechanisms of quinapril and quinaprilat were probed using an isolated perfused rat kidney model. Sixty-four experiments were performed with drug in the absence and presence of classic inhibitors of the organic acid (i.e., probenecid and p-aminohippurate) and organic base (i.e., tetraethylammonium and quinine) transport systems of the proximal tubule. Initial perfusate concentrations of quinapril and quinaprilat were approximately 2.36 microM (or 1000 ng/ml), and transport inhibitors were coperfused at 100-10,000 times the drugs' initial microM concentrations. Quinapril and quinaprilat concentrations were determined in perfusate, urine, and perfusate ultrafiltrate using a reversed-phase HPLC procedure with radiochemical detection, coupled to liquid scintillation spectrometry. Perfusate protein binding was determined using an ultrafiltration method at 37 degrees C. Overall, the clearance ratios of quinapril (total renal clearance divided by fu x GFR) and quinaprilat (urinary clearance divided by fu. GFR) were significantly reduced, and in a dose-dependent manner, by the coperfusion of organic acids but not organic bases. The data demonstrate that the organic anionic secretory system is the primary mechanism by which quinapril and quinaprilat are transported into and across renal proximal cells.
使用离体灌注大鼠肾脏模型探究了喹那普利和喹那普利拉的清除机制。在不存在和存在近端小管有机酸(即丙磺舒和对氨基马尿酸)和有机碱(即四乙铵和奎宁)转运系统的经典抑制剂的情况下,用药物进行了64次实验。喹那普利和喹那普利拉的初始灌注液浓度约为2.36微摩尔/升(或1000纳克/毫升),转运抑制剂以药物初始微摩尔浓度的100 - 10000倍进行共灌注。使用反相高效液相色谱法结合放射化学检测和液体闪烁光谱法测定灌注液、尿液和灌注液超滤液中的喹那普利和喹那普利拉浓度。在37℃下使用超滤法测定灌注液蛋白结合率。总体而言,有机酸共灌注可显著降低喹那普利(总肾清除率除以游离分数×肾小球滤过率)和喹那普利拉(尿清除率除以游离分数×肾小球滤过率)的清除率,且呈剂量依赖性,而有机碱共灌注则无此作用。数据表明,有机阴离子分泌系统是喹那普利和喹那普利拉转运进入并穿过肾近端细胞主要机制。